Showing results (481-490 of 998) with videos related to

Sort By:
Pageof 100
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?J Dmitrewski, S Ayres, B K Gunson, et al.
Lancet (London, England)|November 26, 1994
Policies in Europe on "marginal quality" donor liversD F Mirza, B K Gunson, R F Da Silva, et al.
Journal of Cellular Biochemistry|February 16, 2011
Synthetic small interfering RNA down-regulates caspase-3 and affects apoptosis, IL-1 β, and viability of porcine proximal tubular cellsBin Yang, Joshua E Elias, Maureen Bloxham, et al.
European Journal of Gastroenterology & Hepatology|May 1, 1997
Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosisA E Mahmoud, A S Helmy, L Billingham, et al.
Gut|May 1, 1985
Faecal sulphatase in health and in inflammatory bowel diseaseJ M Rhodes, R Gallimore, E Elias, et al.
Diabetes|December 1, 1993
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipientsA J Krentz, B Dousset, D Mayer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre studyB Ericzon, C Groth, H Bismuth, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipientsJ Devlin, R Williams, P Neuhaus, et al.
Pageof 100